The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
about
Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approachAssociation of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health AdministrationCan rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.Disease activity in rheumatoid arthritis and the risk of cardiovascular events.Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study.Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisThe role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis.Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre StudyImpact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.Incidence and predictors for cardiovascular events in patients with psoriatic arthritis.Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis.Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients.The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients.Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.Arterial stiffness is not increased in patients with short duration rheumatoid arthritis and ankylosing spondylitis.Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.Editorial: Do We Need a Disease-Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis?
P2860
Q26738461-65FE1EDD-023C-457F-A121-64E23D487426Q30885473-DDE21917-E385-4A0A-8579-742C301B74F3Q31043666-CAA7430C-9663-4038-B029-C20C496F6791Q33898530-AB2473B9-747D-4A58-9BAE-BDD783B1D7F4Q35092457-7C45C008-36F3-46F2-A021-A4A5E3C7792DQ35655764-494EC713-52A9-4614-AC90-3E0FA2762DE9Q35814936-E9BF646A-CD2B-4687-A7FD-CE6CDDB7E8DAQ35891702-ED6BEFC2-5375-47CE-B2FF-5189DE0BACAFQ35904678-C97FBE47-3C11-4494-BA7A-0A60F3A39C30Q36054251-3110FFBC-59C1-4C97-AA67-EDFF4B37A01DQ36254129-A3C4502A-80F0-40AD-95CF-8B14F8301076Q37156561-BE8240AF-C703-4227-A663-2A720869F632Q39020908-6B58A132-4F69-4AAD-8752-A8E3FC744B6EQ39037812-D6C74E5B-68C7-43D1-98EC-80CE1C397372Q40073352-B0805D21-5D99-4BBE-A8BB-8A2EA6570DC2Q40386790-57C34EAF-AF53-4B5C-A585-16031D7ECB65Q41192726-4409F6F0-6B45-430D-8C16-E6C07A81E93BQ41728784-59245D7F-C0A3-4CDB-8395-72552CDF5B2BQ46089585-C3649E41-BF99-4A4E-83FE-69B494564AACQ47110507-074871BB-9035-48F1-9207-4D023ABF62DAQ49787347-90041D8F-9656-45B7-80F1-001F1A2404C2Q50122396-34F41BBA-9542-4AF1-B1DF-76BA715FE703Q51126183-318E567B-EF5B-4887-B1E8-74B71399F483Q53024523-4D981ACC-FBF4-4CF5-9F1C-91300B210ED1Q53827279-39DF1B05-DC3B-44A9-A4CF-C6218F67B116Q57751019-C71021EA-DC66-4745-9588-A79B27B67F9D
P2860
The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The effect of disease duration ...... rheumatoid arthritis patients.
@en
The effect of disease duration ...... rheumatoid arthritis patients.
@nl
type
label
The effect of disease duration ...... rheumatoid arthritis patients.
@en
The effect of disease duration ...... rheumatoid arthritis patients.
@nl
prefLabel
The effect of disease duration ...... rheumatoid arthritis patients.
@en
The effect of disease duration ...... rheumatoid arthritis patients.
@nl
P2093
P2860
P1476
The effect of disease duration ...... rheumatoid arthritis patients.
@en
P2093
Calin D Popa
Elke E A Arts
Jaap Fransen
Piet L C M van Riel
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-204531
P407
P577
2014-01-23T00:00:00Z